For the Inventor, By the Inventor

Enter inventor name

South San Francisco, CA, United States of America

Anthony A Estrada

USPTO Granted Patents = 52 (Patent Applications = 31)

CIPO Patents = 8 (Patent Applications = 15)

EPO Patents = 27 (Patent Applications = 38)

Average Co-Inventor Count = 6.6

ph-index = 9

Forward Citations = 218(Granted Patents)

Forward Citations (Not Self Cited) = 160(Dec 10, 2025)

Location History:

San Carlos, CA (US) (2012 - 2021)
South San Francisco, CA (US) (2013 - 2021)
San Mateo, CA (US) (2017 - 2023)
South San Franscisco, CA (US) (2021 - 2023)
Danville, CA (US) (2022 - 2024)

Company Filing History:

Denali Therapeutics Inc.

25 out of 3,222

Genentech, Inc.

Medical Research Council Technology

4. 1 out of 4,945

Hoffmann-la Roche Inc.

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

LRRK2 Inhibitors

Kinase Inhibitors

Eukaryotic Initiation Factor 2B

Substituted Pyrimidines

Biheteroaryl Compounds

Sulfonamide Compounds

Tricyclic DLK Inhibitors

Pyrazole Derivatives

Aminopyrimidine Derivatives

Radioligands for PET Imaging

Neurodegenerative Diseases

Small Molecule Inhibitors

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358928 - Compounds, compositions and methods (2025-07-15),

2. 12358896 - LRRK2 inhibitors and methods of making and using thereof (2025-07-15),

3. 12180211 - Compounds, compositions and methods (2024-12-31),

4. 12139478 - Compounds, compositions and methods (2024-11-12),

5. 12129263 - Kinase inhibitors and uses thereof (2024-10-29),

6. 11958840 - Compounds, compositions and methods (2024-04-16),

7. 11851440 - Modulators of eukaryotic initiation factor 2B, compositions and methods (2023-12-26),

8. 11851433 - Compounds, compositions and methods (2023-12-26),

9. 11840529 - Substituted pyrimidines as LRKK2 inhibitors (2023-12-12),

10. 11834439 - Compounds, compositions, and methods (2023-12-05),

11. 11591316 - Compounds, compositions, and methods (2023-02-28),

12. 11306077 - Compounds, compositions and methods (2022-04-19),

13. 11236100 - Modulators of eukaryotic initiation factor 2B, compositions and methods (2022-02-01),

14. 11236046 - Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators (2022-02-01),

15. 11214565 - Compound, compositions, and methods (2022-01-04),

Title: The Innovative Journey of Anthony A. Estrada

Introduction:

Anthony A. Estrada, a talented inventor based in South San Francisco, CA, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents:

Anthony A. Estrada holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights:

Throughout his career, Anthony A. Estrada has worked tirelessly to bring his inventions to life, with a focus on improving the quality of life for people around the world. His dedication to innovation has led to the development of cutting-edge solutions that have the potential to shape the future.

Collaborations:

Anthony A. Estrada has collaborated with leading research institutions, universities, and tech companies to further his inventions and bring them to market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Anthony A. Estrada is a visionary inventor who continues to push the boundaries of technology with his groundbreaking ideas. His passion for innovation and commitment to making a positive impact on society make him a true pioneer in the field of invention.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…